Literature DB >> 8820895

Acute neurohormonal responses to hypoxaemia in man.

R I Cargill1, L C McFarlane, W J Coutie, B J Lipworth.   

Abstract

We have studied the integrated neuroendocrine and haemodynamic effects of acute hypoxaemia in ten healthy volunteers studied on two separate occasions. After reaching a resting haemodynamic state, subjects breathed either room air or a nitrogen/oxygen mixture which rendered arterial oxygen saturation between 75% and 80%. Measurements of pulmonary and systemic haemodynamics were made and blood samples taken at baseline and after 30 min breathing air or the hypoxic gas. Blood was assayed for plasma sodium and potassium, renin-angiotensin-aldosterone system activity, natriuretic peptides, cortisol and catecholamines. Hypoxaemia significantly increased heart rate, cardiac output and mean pulmonary artery pressure (Ppa), but not mean arterial pressure compared with normoxaemia. Although plasma renin activity, angiotensin II and cortisol were unaffected by hypoxaemia, plasma aldosterone fell significantly in comparison with normoxaemia. This was associated with an increase in plasma atrial natriuretic peptide (ANP) but not b-type natriuretic peptide (BNP) during hypoxaemia whilst no changes were observed during normoxaemia. The increase in plasma ANP correlated positively with the increase in Ppa. During hypoxaemia there is therefore dissociation of the renin-angiotensin-aldosterone system where plasma aldosterone decreased, despite there being no effects on plasma renin activity and angiotensin II or on plasma cortisol. This dissociation may be due to increased levels of ANP but not BNP having specific inhibitory effects on aldosterone biosynthesis. ANP increased in proportion to the degree of pulmonary vasoconstriction induced by hypoxaemia which may indicate a counter-regulatory role.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8820895     DOI: 10.1007/bf00838648

Source DB:  PubMed          Journal:  Eur J Appl Physiol Occup Physiol        ISSN: 0301-5548


  18 in total

1.  Expression of brain natriuretic peptide gene in human heart. Production in the ventricle.

Authors:  K Hosoda; K Nakao; M Mukoyama; Y Saito; M Jougasaki; G Shirakami; S Suga; Y Ogawa; H Yasue; H Imura
Journal:  Hypertension       Date:  1991-06       Impact factor: 10.190

Review 2.  Hypoxic pulmonary vasoconstriction. Physiologic significance, mechanism, and clinical relevance.

Authors:  M Cutaia; S Rounds
Journal:  Chest       Date:  1990-03       Impact factor: 9.410

3.  Comparative effects of atrial natriuretic peptide and brain natriuretic peptide on the aldosterone and pressor responses to angiotensin II in man.

Authors:  R I Cargill; A D Struthers; B J Lipworth
Journal:  Clin Sci (Lond)       Date:  1995-01       Impact factor: 6.124

Review 4.  Doppler ultrasonic measurement of cardiac output: reproducibility and validation.

Authors:  A J Coats
Journal:  Eur Heart J       Date:  1990-12       Impact factor: 29.983

5.  Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery.

Authors:  I S Anand; Y Chandrashekhar; R Ferrari; R Sarma; R Guleria; S K Jindal; P L Wahi; P A Poole-Wilson; P Harris
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

6.  Effect of hypoxia on atrial natriuretic factor and aldosterone regulation in humans.

Authors:  D L Lawrence; J B Skatrud; Y Shenker
Journal:  Am J Physiol       Date:  1990-02

7.  Pulmonary vasorelaxant activity of atrial natriuretic peptide and brain natriuretic peptide in humans.

Authors:  R I Cargill; B J Lipworth
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

8.  Novel double-isotope technique for enzymatic assay of catecholamines, permitting high precision, sensitivity and plasma sample capacity.

Authors:  M J Brown; D A Jenner
Journal:  Clin Sci (Lond)       Date:  1981-11       Impact factor: 6.124

9.  The effects of angiotensin II on circulating levels of natriuretic peptides.

Authors:  R I Cargill; W J Coutie; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1994-08       Impact factor: 4.335

10.  Hypoxia-induced ANP secretion in subjects susceptible to high-altitude pulmonary edema.

Authors:  A Kawashima; K Kubo; Y Matsuzawa; T Kobayashi; M Sekiguchi
Journal:  Respir Physiol       Date:  1992-09
View more
  3 in total

1.  Brain natriuretic peptide and acute hypobaric hypoxia in humans.

Authors:  David Woods; Tim Hooper; Adrian Mellor; Pete Hodkinson; Rob Wakeford; Bob Peaston; Steve Ball; Nic Green
Journal:  J Physiol Sci       Date:  2011-03-24       Impact factor: 2.781

2.  Effects of altitude exposure on brain natriuretic peptide in humans.

Authors:  David Woods; Tim Hooper; Pete Hodkinson; Steve Ball; Rob Wakeford; Bob Peaston; Claire Bairsto; Nic Green; Adrian Mellor
Journal:  Eur J Appl Physiol       Date:  2011-03-11       Impact factor: 3.078

3.  B-type natriuretic peptide levels in congenital heart disease.

Authors:  C G Cowley; J D Bradley; R E Shaddy
Journal:  Pediatr Cardiol       Date:  2004 Jul-Aug       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.